Category: Prescription Drugs
Most Popular Types: Ampyra
See also: Fampridine (4-AP immediate release)
Sort by: Helpfulness | Most Recent
2 patient evaluations for Dalfampridine (4-AP extended release) taken for the purpose of 'MS (Multiple Sclerosis)' with a side effects rating of
| Date | Dosage | Perceived effectiveness | Side Effects | Adherence | Burden |
|---|---|---|---|---|---|
| Jul 23, 2010 | 20 mg Daily |
| Date | Dosage | MS (Multiple Sclerosis) Perceived effectiveness | Improve mobility Perceived effectiveness | Side Effects | Adherence | Burden |
|---|---|---|---|---|---|---|
| Jun 24, 2010 | 20 mg Daily |
17 additional evaluations for Dalfampridine (4-AP extended release) are not currently shared publicly.